Hepatic Dystrophic Calcification Secondary to Transarterial Chemoembolization : Case Report and Review of Literature
Copyright © 2023, Kumar et al..
Hepatocellular carcinoma (HCC) is a common malignancy usually treated with surgery. Patients who are not suitable for surgery undergo transarterial chemoembolization (TACE) which involves injecting anti-cancer drugs and embolizing agents into the hepatic artery. Although it is a relatively safe procedure with minor side effects, TACE can rarely cause dystrophic calcification in the liver. We report a case of a 58-year-old female who presented with right-sided chest pain. The patient had been previously treated for HCC with a TACE procedure. A chest x-ray revealed hepatic calcification which was likely secondary to the prior TACE. This case study emphasizes the significance of considering TACE as a potential cause of hepatic dystrophic calcification.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Cureus - 15(2023), 3 vom: 28. März, Seite e35765 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Vikash [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Calcification |
|---|
| Anmerkungen: |
Date Revised 07.04.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.7759/cureus.35765 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355251906 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355251906 | ||
| 003 | DE-627 | ||
| 005 | 20231226063946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7759/cureus.35765 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1184.xml |
| 035 | |a (DE-627)NLM355251906 | ||
| 035 | |a (NLM)37020485 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kumar, Vikash |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatic Dystrophic Calcification Secondary to Transarterial Chemoembolization |b Case Report and Review of Literature |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.04.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2023, Kumar et al. | ||
| 520 | |a Hepatocellular carcinoma (HCC) is a common malignancy usually treated with surgery. Patients who are not suitable for surgery undergo transarterial chemoembolization (TACE) which involves injecting anti-cancer drugs and embolizing agents into the hepatic artery. Although it is a relatively safe procedure with minor side effects, TACE can rarely cause dystrophic calcification in the liver. We report a case of a 58-year-old female who presented with right-sided chest pain. The patient had been previously treated for HCC with a TACE procedure. A chest x-ray revealed hepatic calcification which was likely secondary to the prior TACE. This case study emphasizes the significance of considering TACE as a potential cause of hepatic dystrophic calcification | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a calcification | |
| 650 | 4 | |a hepatic calcification | |
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a transarterial chemoembolization | |
| 650 | 4 | |a transarterial chemoembolization adverse event | |
| 700 | 1 | |a Shah, Mili |e verfasserin |4 aut | |
| 700 | 1 | |a Gala, Dhir |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Manmeet K |e verfasserin |4 aut | |
| 700 | 1 | |a Jeanty, Herby |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Reeny |e verfasserin |4 aut | |
| 700 | 1 | |a Forlemu, Arnold N |e verfasserin |4 aut | |
| 700 | 1 | |a Gayam, Vijay Reddy |e verfasserin |4 aut | |
| 700 | 1 | |a Etienne, Denzil |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 15(2023), 3 vom: 28. März, Seite e35765 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:3 |g day:28 |g month:03 |g pages:e35765 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.35765 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 3 |b 28 |c 03 |h e35765 | ||